Search results
Gen X May Face Higher Cancer Rates Than Baby Boomers
WebMD· 3 days agoGen-Xers are more likely to be diagnosed with cancer than generations that came before them, according to a new study published in JAMA Open Network. Researchers from the National Cancer Institute ...
Not just a Gulf of Mexico problem: Mississippi River farm runoff pollutes upstream waters
Biloxi Sun Herald via Yahoo News· 4 days agoWorsening local effects on health and recreation in states like Minnesota and Wisconsin are spurring...
Researchers provide a review and update on therapy of gastrointestinal tract tumors
Medical Xpress· 6 days agoGastrointestinal (GI) cancers, encompassing esophageal, gastric, small bowel, and colorectal...
Newswise Expert | Heinz-Josef Lenz, Keck Medicine of USC
Newswise· 5 days agoHeinz-Josef Lenz, M.D., FACP, is the Associate Director for Clinical Research and Co-Leader of the Gastrointestinal Cancers Program at the USC Norris Comprehensive Cancer Center. Dr. Lenz is ...
Regeneron (NASDAQ:REGN): Is This Stock-Split Contender a Strong Buy?
TipRanks via Yahoo Finance· 4 days agoRegeneron (NASDAQ:REGN) stock has more than tripled in value in the past five years, with the price...
Summer is perfect for Watermelon Seed Spitting Week
Shreveport Times | The Times via Yahoo News· 2 days agoApparently, recent studies have shown that consuming onions is healthy, helping the body fight colorectal cancer and breast cancer, heart disease, and diabetes ...
Actuate Therapeutics (ACTU) to Raise $50 Million in IPO
ETF DAILY NEWS· 5 days agoActuate Therapeutics (ACTU) plans to raise $50 million in an initial public offering on the week of...
Market Today: Eli Lilly's Tirzepatide Success, AeroVironment Fac
Guru Focus· 3 days agoThe market showed mixed action on this quadruple witching options expiration day, leading to...
Study highlights importance of early detection in bile duct cancer for patients with rare liver...
Medical Xpress· 4 days agoPrimary sclerosing cholangitis (PSC) is a rare progressive liver disease that damages bile ducts and significantly increases the risk of bile duct cancer, particularly a type called cholangiocarcinoma ...
GenFleet Receives IND Approval from China's NMPA for GFH375, an Oral KRAS G12D (ON/OFF) Inhibitor,...
Tehachapi News· 5 days agoGenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced China's National Medical Products Administration (NMPA) ...
